Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDA-II in low- and intermediate-1 risk MDS
CTR20140545Phase 2Active
- Sponsor
- Hefei Yongsheng Pharmaceutical
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cladribine in myelodysplastic syndrome (MDS), sponsored by Hefei Yongsheng Pharmaceutical. Started Aug 2014; status: active.
02
Drugs
cladribine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on CTR20140545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140545.